Independent investment company Breakthrough Victoria is investing $800,000 in Diag-Nose.io Medical (DNM), a Melbourne based ...

The Allan Labor Government is backing local medical technology startup Diag-Nose Medical to develop new treatments for chronic respiratory disorders ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

As contemporary surgical practice continues to evolve, patients who undergo surgical lung volume reduction (LVRS) for ...

Recognizing the signs of COPD, which include shortness of breath, chronic cough, and increased mucus production, can lead to a diagnosis and treatment plan that improves the chances of slowing ...

For patients with advanced emphysema, endobronchial valve placement (EBV) is associated with higher mortality and morbidity ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...